If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

Inlicensing opportunities

Popular

Description

Inlicensing opportunities for Indian Market

Unichem Laboratories Limited is a globally operating, India-based pharmaceutical company. We are among the top 25 companies in the Indian market with current turnover exceeding US$ 140 million and presence in key therapeutic segments like Cardio, Diabeto, CNS, Anti-infectives, Gastro-intestinals, Pain management,Respiratory, Dermatology, Nephrology.

The various divisions have a collective field force of about 1500 employess and they meet about 1,50,000 doctors across India.
We have reach of around 40 distributors, more than 4000 stockists and more than 5,00,000 retailers cross India. We are looking for in-licensing opportunities for various pharmaceutical products for the Indian market in the following therapeutic segments:CNSDermatology/CosmetologyPain ManagementDiabetologyCardiologyGastro-intestinalsAnti-infectivesVitamins/Minerals/Nutrients. We would be also happy to discuss NDDS versions of various products.

Kind Regards,

Gaurav Lakhani

Business Development Manager

More details

Name Description
Pharma licensing In-licensing (demand)

Ad details

Ad ID : 573

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
191 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
184 Views
Profitable and Modern Russian CMO with long...
166 Views
Adalimumab API available: - from EU cGMP...
9887 Views
Infliximab API available: - from EU cGMP...
197 Views
Normal 0 false false false EN-US X-NONE HE /*...
178 Views
Start-up pharmaceutical company from South...
1504 Views